COVID-19 Medicine Update

COVID-19 Medicine Update: Restricted Emergency Use authorizations (EUA) for Medications in India

The national regulatory body for Indian pharmaceuticals and medical devices- Central Drugs Standard Control Organisation (CDSCO) has provided approval as part of restricted & emergency use authorization for the below two medicines considering the unmet medical need for treatment of COVID-19 infected patients- Favipiravir Tablets for mild to moderate COVID-19 infection subject to various conditions

error: Content is protected !!